Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-12 12:14 pm Unchanged | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | VANGUARD GROUP INC | 1,940,388 5.650% | 0 (Unchanged) | Filing History |
2024-11-04 10:59 am Purchase | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | VANGUARD GROUP INC | 1,940,388 5.650% | 1,940,388 (New Position) | Filing History |
2024-10-31 12:38 pm Purchase | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | FRANKLIN RESOURCES INC BEN | 6,052,374 16.600% | 1,686,619 (+38.63%) | Filing History |
2024-10-25 4:53 pm Purchase | 2024-09-30 | 13G | Achieve Life Sciences, Inc. ACHV | BlackRock Inc. BLK | 2,071,132 6.000% | 2,071,132 (New Position) | Filing History |
2024-05-20 5:01 pm Purchase | 2023-12-31 | 13G | Achieve Life Sciences, Inc. ACHV | Contrarian Alpha LP | 2,303,377 6.600% | 205,000 (+9.77%) | Filing History |
2024-05-17 2:56 pm Purchase | 2024-03-04 | 13G | Achieve Life Sciences, Inc. ACHV | Propel Bio Management LLC | 2,334,176 6.810% | 2,334,176 (New Position) | Filing History |
2024-03-11 1:44 pm Purchase | 2024-02-29 | 13G | Achieve Life Sciences, Inc. ACHV | FRANKLIN RESOURCES INC BEN | 4,365,755 12.000% | 4,365,755 (New Position) | Filing History |
2024-02-27 3:32 pm Purchase | 2022-11-15 | 13G | Achieve Life Sciences, Inc. ACHV | Callahan Patrick J. III | 2,167,439 9.900% | 2,167,439 (New Position) | Filing History |
2023-06-02 5:19 pm Purchase | 2023-05-25 | 13G | Achieve Life Sciences, Inc. ACHV | Contrarian Alpha LP | 2,098,377 9.700% | 2,098,377 (New Position) | Filing History |
2023-04-18 5:18 pm Purchase | 2023-04-18 | 13G | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,593,093 19.990% | 44,093 (+1.24%) | Filing History |
2023-03-23 4:45 pm Unchanged | 2023-03-21 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing History |
2023-03-06 10:43 am Unchanged | 2023-03-01 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing History |
2023-02-13 4:34 pm Purchase | 2022-12-31 | 13G | Achieve Life Sciences, Inc. ACHV | Francis Capital Management LLC | 682,798 3.800% | 88,548 (+14.90%) | Filing History |
2023-02-10 4:04 pm Purchase | 2022-12-31 | 13G | Achieve Life Sciences, Inc. ACHV | SVB FINANCIAL GROUP SIVBQ | 1,716,764 8.800% | 9,959 (+0.58%) | Filing History |
2023-01-20 3:02 pm Unchanged | 2023-01-19 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing History |
2022-11-28 10:32 am Purchase | 2022-11-18 | 13G | Achieve Life Sciences, Inc. ACHV | Contrarian Achieve SPV LP | 1,367,873 7.643% | 1,367,873 (New Position) | Filing History |
2022-11-22 4:00 pm Purchase | 2022-11-18 | 13G | Achieve Life Sciences, Inc. ACHV | SVB FINANCIAL GROUP SIVBQ | 1,706,805 8.700% | 100,812 (+6.28%) | Filing History |
2022-11-21 4:41 pm Purchase | 2022-11-18 | 13G | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 3,549,000 (New Position) | Filing History |
2022-02-14 2:02 pm Purchase | 2021-12-31 | 13G | Achieve Life Sciences, Inc. ACHV | Francis Capital Management LLC | 594,250 6.300% | 253,100 (+74.19%) | Filing History |
2021-12-29 4:00 pm Purchase | 2021-12-22 | 13G | Achieve Life Sciences, Inc. ACHV | SVB FINANCIAL GROUP SIVBQ | 1,605,993 14.500% | 1,605,993 (New Position) | Filing History |